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Abstract
Background: Ageing, inactivity and obesity are associated with chronic low-grade inflammation contributing to
a variety of lifestyle-related diseases. Transforming growth factor-β (TGF-β) is a multimodal protein with various
cellular functions ranging from tissue remodelling to the regulation of inflammation and immune functions. While
it is generally accepted that aerobic exercise exerts beneficial effects on several aspects of immune functions, even
in older adults, the effect of resistance training remains unclear. The aim of this study was to investigate whether
progressive resistance training (6 months) with or without nutritional supplementation (protein and vitamins) would
influence circulating C-reactive protein and TGF-β levels as well as TGF-β signalling in peripheral mononuclear cells
(PBMCs) of institutionalised adults with a median age of 84.5 (65.0–97.4) years.
Results: Elastic band resistance training significantly improved performance as shown by the arm-lifting test (p = 0.007),
chair stand test (p = 0.001) and 6-min walking test (p = 0.026). These results were paralleled by a reduction in TGF-β
receptor I (TGF-βRI) mRNA expression in PBMCs (p = 0.006), while circulating inflammatory markers were unaffected.
Protein and vitamin supplementation did not provoke any additional effects. Interestingly, muscular endurance of upper
and lower body and aerobic performance at baseline were negatively associated with changes in circulating TGF-β at
the early phase of the study. Furthermore, drop-outs of the study were characterised not only by lower physical
performance but also higher TGF-β and TGF-βRI mRNA expression, and lower miRNA-21 expression.
Conclusions: Progressive resistance training with elastic bands did not influence chronic low-grade inflammation
but potentially affected TGF-β signalling in PBMCs through altered TGF-βRI mRNA expression. There appears to be
an association between physical performance and TGF-β expression in PBMCs of older adults, in which the exact
mechanisms need to be clarified.
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Background
Population ageing resulting from a higher life expectancy
concomitant with a decline in fertility will lead to a
global increase in the proportion of people over the age
of 60 years from 12 % in 2015 to 22 % by 2050 [1]. With
higher ages, the prevalence of cardiovascular, metabolic
and neurodegenerative disorders and cancer is increased.
It has been shown that many of these conditions are
related to compromised homeostasis between proper
activation of the immune system and its resolution, lead-
ing to a limited response to pathogens and vaccines and
a chronic inflammatory state [2, 3].
Transforming growth factor-β (TGF-β) is a multifunc-
tional protein involved in the regulation of cell prolifera-
tion, extracellular matrix production, inflammation and
immune functions [4]. Higher circulating levels of TGF-
β are related to obesity with impaired insulin sensitivity
[5], cardiovascular diseases among individuals with
higher C-reactive protein (CRP) levels [6], type II
diabetes [7, 8], and a higher age [9]. TGF-β interacts
with several cell types by binding to membrane serine/
threonine kinase receptors, TGF-β receptor I (TGF-βRI;
also known as ALK5) and TGF-βRII, initiating diverse
cellular responses [10]. An approach to modulate TGF-β
signalling is to alter the expression of its receptors. It
has become evident that microRNAs (miRNAs) regulate
thousands of human genes by either mRNA degradation
or suppression of mRNA translation [11]. A recent inves-
tigation estimated that 84–89 % of miRNA-induced
suppression of gene expression is the result of degradation
of target mRNAs [12]. Currently, close to 1900 human
miRNA precursors are listed in the miRBase registry,
which give rise to 2588 mature miRNAs [13, 14]. One of
these miRNAs, miRNA-21, plays a crucial role in a pleth-
ora of biological functions and diseases including the
development of cancer, cardiovascular diseases and
inflammation [15]. Interestingly, miRNA-21 targets both
TGF-βRI and TGF-βRII [16], and overexpression of
miRNA-21 is associated with elevated levels of proinflam-
matory cytokines in a dominant-negative TGF-βRII mouse
model [17].
Regular physical activity offers protection against, and
may be a useful treatment for, a wide variety of chronic
diseases associated with low-grade inflammation [18]. In
particular, endurance exercise training combined with
dietary weight loss strategies have been shown to
decrease the chronic inflammatory state associated with
obesity and old age [19, 20]. Resistance training prevents
or counteracts age-related loss of muscle mass and
functions [21, 22], but there is an ongoing discussion
whether this type of exercise alters the chronic inflam-
matory state associated with ageing [23–25].
In the Vienna Active Ageing Study (VAAS), we previ-
ously showed that resistance training using elastic bands
for 6 months leads to an increase in functional perform-
ance of the lower and upper extremities and improves
muscle quality in older people [22, 26]. Furthermore, we
detected higher CRP levels and lower TGF-βRI and
TGF-βRII expression in peripheral blood mononuclear
cells (PBMCs) of older women compared with younger
women [27]. Therefore, the aim of this sub-study of the
VAAS was to investigate whether progressive resistance
training alone or in combination with a nutritional
supplement containing protein and vitamins influenced




A total of 230 potential participants were screened for
eligibility, and 117 participants (89 women and 12 men)
agreed to participate in the VAAS. The participants were
randomised into intervention groups: cognitive training
(CT), resistance training (RT), and resistance training plus
nutritional supplementation (RTS) (Fig. 1). Blood samples
were available from 95 participants (84 women and 11
men). To prevent any potential interference by acute
inflammatory processes, we excluded all subjects with CRP
levels above 10 mg/L at any time point as done previously
[28, 29]. Finally, data from 88 participants (77 women and
11 men) with a median age of 84.5 (65.2–97.4) years and a
median body mass index (BMI) of 28.9 (18.1–50.0) kg/m2
were included in the current study (Fig. 1). No differences
between study groups with respect to age, gender,
anthropometric data and health status were detected at
baseline, whereas leukocyte numbers differed significantly
between intervention groups (p = 0.002). Post-hoc analyses
revealed that subjects from the RT group had lower
leukocyte numbers than those from the CT group (+28 %,
p = 0.002) and the RTS group (+19 %, p = 0.039), which was
owing to lower numbers of neutrophils (CT: +51 %,
p < 0.001; RTS: +33 %, p = 0.092). Circulating inflamma-
tory markers (hs-CRP and TGF-β) and mRNA expression
of TGF-β, its receptors and miRNA-21 in PBMCs
(lymphocytes and monocytes) did not differ between
groups at baseline (Table 1).
Dropout analysis
During 6 months of intervention, 18 women and 3 men
(27 %) left the study because of several reasons (loss of
interest or acute medical reasons such as joint pain or
cardiological issues). The dropout rate did not differ
between groups. In addition, age, sex, and existing co-
morbidities in general were not related to adherence to
the study. Only the number of participants diagnosed
for hyperlipidaemia was higher in finishers compared
with the dropouts (p = 0.016). Baseline performance
appeared to be related to study adherence because
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dropouts had lower aerobic (6MWT: −19 %, p = 0.020)
and chair stand (−13 %, p = 0.015) performance than
finishers of the study. Strength (p = 0.608) and muscular
endurance (p = 0.924) of the upper extremities were not
different between finishers and dropouts. The observed
differences also became evident in some of the TGF-β-
related parameters because TGF-β (+106 %, p = 0.016)
and TGF-βRI (+237 %, p < 0.001) mRNA expression was
higher in dropouts, while miRNA-21 expression was
lower (−65 %, p < 0.001) (Table 2). As a consequence
we performed a per-protocol analysis by excluding the
dropouts from all subsequent analyses (Tables 3 and 4).
Resistance training improves physical performance of
older subjects
We have previously shown that resistance training inter-
vention specifically improved muscular endurance (chair
stand and arm-lifting tests), while isometric strength
(handgrip test) and aerobic capacity (6-min walking test;
6MWT) increased similarly in CT, RT and RTS groups
[22]. Because the current study included just a subset of
the original study population, the data on physical perform-
ance were re-analysed. At baseline, no differences in any of
the physical fitness parameters were observed between
intervention groups (p > 0.05). Similar to the previous
results, chair stand performance was increased in the RT
group (3 months: +18 %, p = 0.041; 6 months: +27 %,
p = 0.001) and RTS group (6 months: +15 %, p = 0.017).
Arm-lifting performance was enhanced in RT and
RTS groups only after 6 months (RT: +24 %, p = 0.007;
RTS +61 %, p = 0.007). While handgrip strength was un-
altered over time in all intervention groups (CT: p = 0.454;
RT: p = 0.238, RTS: p = 0.810), aerobic performance during
the 6MWT was slightly improved in the RT group after
6 months (+9 %, p = 0.026) but not in the CT or RTS
groups (CT: p = 0.959, RTS: p = 0.080) (data not shown).
Effects of interventions on leukocyte subpopulations and
circulating inflammatory markers
Except for an adaptation of the leukocyte numbers in
the RT group (overall: p = 0.001; 3 months: p = 0.166;
6 months: p = 0.001; +7 %) caused by an increase in neu-
trophils (overall: p = 0.011; 3 months: p = 0.166; 6 months:
p = 0.010 + 22 %), we did not detect any other alterations
in leukocyte, lymphocyte, monocyte or granulocyte
counts. Similarly, the circulating levels of TGF-β and
hs-CRP remained unchanged (Table 3).
Influence of interventions on intracellular TGF-β and TGF-β
receptor mRNA expression, and miRNA-21 expression
The mRNA expression of TGF-β, TGF-βRI, TGF-βRII
and miRNA-21 in PBMCs did not differ between groups
at any time point. Resistance training led to a significant
decrease in TGF-βRI mRNA levels (p = 0.006). Post-hoc
analyses revealed that the initial decrease at 3 months
(−27 %, p = 0.015) was reversed at 6 months (p = 0.117).
Interestingly, this decrease could not be confirmed in
the RTS group, although the median level decreased
similarly to the RT group. Intracellular TGF-β and
TGF-βRII mRNA expression, and miRNA-21 expres-
sion, were not influenced by any of the interventions
(Table 4).
Because resistance training only led to marginal changes
in the TGF-β signalling pathway, we examined whether
Fig. 1 Participant flow
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different components of physical fitness (strength, muscular
endurance and aerobic performance) at baseline influenced
the TGF-β signalling response (difference between 3 or
6 months and baseline values). While isometric handgrip
strength was not associated with alterations in TGF-β-
related parameters, muscular endurance and aerobic
performance at baseline were negatively associated with
changes in circulating TGF-β levels after 3 months (chair
rise test: ρ = −0.349, p = 0.003, arm-lifting test: ρ = −0.352,
p = 0.024; 6MWT: ρ =−0.308, p = 0.009), but chair stand
performance was positively associated with changes in
TGF-βRII mRNA expression (ρ = 0.254, p = 0.033)
(Table 5).
Discussion
The aim of the current study was to investigate the
effects of progressive resistance training alone and in
combination with a nutritional supplement enriched
with protein and vitamins on systemic inflammation
and TGF-β signalling in PBMCs of institutionalised,
but independent older people. Circulating TGF-β and
hs-CRP levels as well as intracellular TGF-β gene expres-
sion were not influenced by elastic band resistance
training. Interestingly, TGF-βRI, but not TGF-βRII, gene
expression was reduced in the RT group after 3 months
and returned to baseline levels thereafter.
It is well known that regular endurance training
reduces the chronic proinflammatory state caused by
ageing and physical inactivity [30, 31]. Adipose tissue
appears to play a substantial role in this scenario
because it is a major source of several hormones and
cytokines [32]. In particular, visceral fat depots and the
macrophages within these depots release proinflamma-
tory cytokines such as interleukin-6 (IL-6), tumour
necrosis factor-α (TNF-α) and TGF-β1 [33]. The in-
crease in energy expenditure caused by enhanced phys-
ical activity reduces body fat, thereby influencing the
capacity to produce and release proinflammatory media-
tors [33]. Recommended strategies to lose weight and
body fat include aerobic exercise training combined with
Table 1 Baseline characteristics
All (n = 88) CT (n = 30) RT (n = 32) RTS (n = 26) P-value
Gender [female/male] 77/11 25/5 28/4 24/2 0.602
Age [years] 84.5 (65.0–97.4) 84.5 (69.4–97.4) 84.4 (71.7–93.2) 84.3 (65.0–92.2) 0.864
BMI [kg/m2] 28.9 (18.1–50.0) 29.8 (18.1–36.9) 28.2 (22.7–40.2) 27.9 (22.9–50.0) 0.741
Obesity [n (%)] 32 (36.8 %) 14 (46.7 %) 8 (25.0 %) 10 (35.7 %) 0.235
Hyperlipidaemia [n (%)] 32 (36.4 %) 9 (30.0 %) 10 (31.3 %) 13 (46.4 %) 0.226
Diabetes Type II [n (%)] 14 (15.9 %) 6 (20 %) 7 (21.9 %) 1 (3.6 %) 0.132
Hypertension [n (%)] 70 (79.5 %) 26 (86.7 %) 27 (84.4 %) 17 (60.7 %) 0.100
Cardiac diseases [n (%)] 27 (30.7 %) 12 (40.0 %) 9 (28.1 %) 6 (21.4 %) 0.362
Osteoporosis [n (%)] 35 (39.8 %) 12 (40.0 %) 12 (37.5 %) 11 (39.3 %) 0.933
History of cancer [n (%)] 12 (13.6 %) 5 (16.7 %) 4 (12.5 %) 3 (10.7 %) 0.833
Leukocyte subpopulations and circulating biomarkers
Leukocytes [x109 cells/L] 6.6 (3.3–13.0) 7.4 (4.9–10.3)* 5.8 (3.1–9.8) 6.9 (4.4–13.3)* 0.002
Lymphocytes [cells/μl] 1990 (930–4930) 1985 (910–3510) 1835 (830–3330) 2200 (1460–4700) 0.085
Neutrophils [cells/μl] 3695 (1530–9860) 4414 (2410–6630)* 2931 (1530–6800) 3889 (2370–9860) <0.001
Eosinophils [cells/μl] 200 (10–740) 225 (36–620) 160 (10–740) 220 (10–470) 0.135
Basophils [cells/μl] 40 (10–111) 45 (10–111) 35 (10–190) 35 (10–90) 0.397
Monocytes [cells/μl] 560 (250–910) 587 (72–950) 520 (260–860) 545 (320–960) 0.189
hs-CRP [mg/L] 1.95 (0.3–7.9) 2.1 (0.5–7.9) 1.9 (0.3–7.6) 1.9 (0.6–6.7) 0.918
TGF-β [μg/L] 33.3 (16.7–73.7) 38.2 (18.7–73.7) 32.8 (16.7–55.4) 32.1 (21.0–51.2) 0.083
PBMC gene expression
TGF-β/GAPDH [-] 0.85 (0.06–3.36) 0.48 (0.23–2.66) 0.60 (0.21–2.52) 0.58 (0.06–3.36) 0.725
TGF-βRI/GAPDH [-] 2.05 (0.14–28.82) 1.99 (0.14–22.39) 2.04 (0.69–19.25) 2.11 (0.29–28.81) 0.990
TGF-βRII/GAPDH [-] 1.67 (0.51–15.85) 1.54 (0.66–7.79) 1.60 (0.66–14.85) 1.79 (0.51–10.80) 0.714
miRNA–21 [copies/pg] 2400 (57–4720) 2920 (343–4500) 2120 (57–4720) 2350 (550–4590) 0.765
Data are expressed as medians (min–max); Group differences were detected using X2 or Kruskal–Wallis tests and if significant, followed by Bonferroni-corrected
post-hoc analyses (*p < 0.05 vs. RT); significant differences are marked in bold
Abbreviations: CT cognitive training, RT resistance training, RTS resistance training plus supplement, PBMC peripheral blood mononuclear cell, hs-CRP high sensitive
C-reactive protein, TGF-β transforming growth factor-β, TGF-βR TGF-β receptor, GAPDH glyceraldehyde 3-phosphate dehydrogenase, miR-21 microRNA-21
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caloric reduction. Although it is known that resistance
training does not promote clinically significant weight
loss, it influences body composition by increasing
muscle mass and decreasing body fat [34, 35]. Thus, it
has been hypothesised that muscle-strengthening exer-
cises also exert anti-inflammatory effects. Based on
intervention studies investigating the effects of strength
training on inflammatory markers such as CRP, TNF-α
and IL-6, the data are ambiguous because some studies
have revealed a positive effect [23, 36], whereas others
did not observe any amelioration in the inflammatory
state [24, 25, 37]. While the TGF-β superfamily has been
studied extensively in the adaptation of muscles and
tendons to exercise [38], investigations into the context
of exercise immunology are scarce. Our data are in line
with a previous study showing that strength training
does not alter the level of circulating TGF-β [39].
Another study, investigating the influence of a combined
strength and endurance exercise programme in type 2
diabetic patients revealed an increase in circulating
TGF-β [36], but study population and training
programme were different making a direct comparison
difficult. Nevertheless, in our study, parameters measur-
ing aerobic fitness and muscular endurance, but not
handgrip strength, correlated negatively with TGF-β
alterations. This could hint to the fact that endurance
training is an important component of an exercise inter-
vention to target circulating TGF-β levels, but further
studies are needed to clearly identify the underlying
associations.
While circulating levels of TGF-β were unaffected, our
data revealed that resistance training seems to lower the
TGF-βRI mRNA expression in PBMCs of older adults,
potentially leading to decreased signalling through the
type I receptor. Furthermore, higher levels of TGF-βR1
mRNA were detected in the less fit dropouts. As the
mRNA was extracted from isolated PBMCs which
include lymphocytes and monocytes, but not neutrophils
or erythrocytes, it is very unlikely that the observed
alterations in TGF-βRI mRNA are directly caused by
varying neutrophil counts between groups. However,
due to the pleiotropic effects of TGF-β, it is difficult to
interpret the clinical implication of these findings. While
TGF-β signalling is essential for regulatory T (Treg) cell
maturation and immune homeostasis [40, 41], excessive
signalling may lead to dysregulated TReg cell activity and
may underlie a diverse range of allergic diseases in
humans [42, 43]. Drugs which aim to block the TGF-β
signalling are under investigation in connection with
several disorders such as hypertrophic cardiomyopathy
[44], hypertension [45] or the Marfan syndrome [46] and
are suggested to be valuable for treating food allergies
[42]. Therefore, the observed alterations in TGF-βRI
mRNA expression caused by resistance training could be
beneficial in these situations, whereby future studies
need to clarify whether lower mRNA levels de facto lead
Table 2 Baseline differences between drop-outs and finishers
Total (n = 88) Dropouts (n = 21) Non-Dropouts (n = 67) p-value
Gender [female/male] 77/11 18/3 59/8 0.777
Age [years] 84.5 (65.0–97.4) 85.2 (69.4–92.2) 84.2 (65.0–97.4) 0.282
BMI [kg/m2] 28.9 (18.1–50.0) 28.3 (18.1–43.7) 30.7 (23.4–50.0) 0.094
hs-CRP [mg/L] 1.9 (0.3–7.9) 2.0 (0.8–7.9) 1.9 (0.3–7.6) 0.413
TGF-β signalling
TGF-β [μg/L] 33.3 (16.7–73.7) 39.3 (22.5–58.0) 32.8 (16.7–73.7) 0.178
TGF-β/GAPDH [-] 0.53 (0.06–3.36) 1.07 (0.21–3.36) 0.52 (0.06–2.66) 0.016
TGF-β RI/GAPDH [-] 2.05 (0.14–28.81) 6.41 (1.31–28.81) 1.90 (0.14–22.39) <0.001
TGF-β RII/GAPDH [-] 1.67 (0.51–14.85) 3.00 (0.91–10.80) 1.59 (0.51–14.85) 0.099
miR–21 [copies/pg RNA] 2400 (57–5720) 979 (498–3640) 2815 (57–4720) <0.001
Co-morbidities
Obesity [n (%)] 32 (36.4 %) 10 (47.6 %) 22 (32.8 %) 0.162
Hyperlipidemia [n (%)] 32 (36.4 %) 3 (14.2 %) 29 (43.3 %) 0.016
Diabetes Type II [n (%)] 14 (15.9 %) 3 (14.3 %) 11 (16.4 %) 0.816
Hypertension [n (%)] 70 (79.5 %) 17 (81.0 %) 53 (79.1 %) 0.855
Cardiac diseases [n (%)] 27 (30.7 %) 7 (33.3 %) 20 (29.9 %) 0.763
Osteoporosis [n (%)] 35 (39.8 %) 9 (42.9 %) 26 (38.8 %) 0.741
History of cancer [n (%)] 12 (13.6 %) 3 (14.3 %) 9 (13.4 %) 0.921
Data for continuous variables are shown as medians (min–max). For co-morbidities, the respective numbers of affected participants were determined at the
medical entrance examination. Obesity was defined as a BMI of >30 kg/m2. Differences between groups were determined by Mann–Whitney U or X2 tests;
significant differences are marked in bold
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to a lower expression of the receptor on the surface of
the respective cells and whether these changes are clinic-
ally relevant.
It has to be mentioned that the median TGF-βR1
mRNA expression was slightly lower in both, the RT and
the RTS group (-14 % and -16 %, respectively), but
reached significance only in the RT group. For physical
performance (chair stand and arm lifting performance)
similar gains could be detected in both groups. A recent
systematic review demonstrated that combining protein
supplementation with resistance training is effective for
eliciting gains in fat-free mass among older adults, but
does not appear to further increase muscle mass or
strength, which was similar to our study [47]. In addition
to proteins, the supplement in this study contained
several vitamins. Based on previous analyses, this supple-
ment aids to increase the uptake of vitamin D and folic
acid as well as the plasma levels of vitamin B12 and folic
acid in erythrocytes [48, 49]. As some of the variables in
this study (TGF-βRI mRNA expression, leukocyte
Table 3 Intervention effects on leukocyte subpopulations and circulating inflammatory markers
Baseline (n = 67) 3 months (n = 67) 6 months (n = 67) P-value (time)
Leukocytes [x109 cells/L]
CT (n = 26) 7.2 (4.9–10.3)** 7.2 (4.1–11.9) 7.1 (5.4–9.4) 0.440
RT (n = 20) 5.6 (3.1–9.1) 6.0 (3.2–8.9) 6.0 (3.3–9.8)* 0.001
RTS (n = 21) 7.0 (4.4–13.3)** 7.2 (4.5–11.7)** 7.1 (4.7–13.0) 0.586
Lymphocytes [cells/μl]
CT (n = 26) 1985 (910–3510) 2090 (890–3980) 2250 (930–3540) 0.387
RT (n = 20) 1675 (830–3330) 1765 (912–3190) 1720 (1010–3430) 0.651
RTS (n = 21) 2255 (1460–4700) 2340 (1570–4680) 2190 (1640–4930) 0.810
Monocytes [cells/μl]
CT (n = 26) 610 (72–950) 550 (300–780) 590 (400–910) 0.534
RT (n = 20) 520 (260–790) 475 (250–960) 510 (250–880) 0.104
RTS (n = 21) 585 (320–960) 490 (300–840) 545 (330–900) 0.404
Neutrophils [cells/μl]
CT (n = 26) 4300 (2410–6630)** 4010 (1990–7420) 3910 (3110–5880) 0.247
RT (n = 20) 2876 (1530–6800) 3390 (1720–5880) 3520 (1800–7330)* 0.011
RTS (n = 21) 4030 (2430–9860) 3930 (1720–8730) 4290 (1664–8680) 0.368
Basophils [cells/μl]
CT (n = 26) 40 (20–111) 30 (10–90) 30 (20–100) 0.027
RT (n = 20) 35 (10–90) 30 (10–100) 30 (10–80) 0.878
RTS (n = 21) 40 (10–90) 40 (10–90) 40 (10–80) 0.344
Eosinophils [cells/μl]
CT (n = 26) 210 (36–448) 170 (80–470) 220 (90–330) 0.911
RT (n = 20) 160 (10–690) 186 (40–530) 200 (80–570) 0.381
RTS (n = 21) 248 (90–470) 195 (20–630) 260 (90–650) 0.137
hs-CRP [mg/L]
CT (n = 26) 2.0 (0.5–4.8) 2.4 (0.2–5.5) 1.8 (0.3–8.5) 0.424
RT (n = 20) 1.9 (0.3–7.6) 2.4 (0.5–7.7) 2.0 (0.6–9.6) 0.645
RTS (n = 21) 1.8 (0.6–5.4) 2.1 (0.6–8.5) 1.6 (0.4–5.5) 0.135
TGF-β [μg/L]
CT (n = 26) 36.0 (18.7–73.7) 39.8 (18.4–67.8) 40.8 (21.9–67.9) 0.953
RT (n = 20) 31.5 (16.7–50.0) 34.5 (18.3–59.7) 34.6 (12.7–57.3) 0.075
RTS (n = 21) 33.7 (21.0–51.2) 38.0 (22.9–50.5) 35.5 (22.1–52.1) 0.431
Data are expressed as medians (min–max); Differences over the time course were detected using the Friedman test and if significant, followed by Bonferroni-corrected
post-hoc analyses (*p< 0.05 vs. baseline within respective study group). Differences between groups were analysed by Kruskal Wallis test, followed by Bonferroni-corrected
post-hoc analyses (**p< 0.05 vs. RT group within respective time point; significant differences are marked in bold) Abbreviations: CT cognitive training, RT resistance training,
RTS resistance training plus supplement, hs-CRP high sensitive C-reactive protein, TGF-β transforming growth factor-β
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numbers, 6MWT) were altered in the RT but not in the
RTS group, it seems that the supplement prevented
some of the responses to exercise. There is an ongoing
discussion whether antioxidant supplementation may
even blunt an exercise-induced training effect [50]. Evi-
dence indicates that reactive oxygen species modulate
TGF-β signalling. In turn, TGF-β increases the produc-
tion of reactive oxygen species and suppresses antioxi-
dant enzymes [51]. Therefore, it cannot be excluded that
rigorous scavenging of free radicals impaired the TGF-β
pathway response in the RTS group.
A reduction in TGF-βRI expression can be caused by
either lower production or an increase in degradation of
its mRNA. Post-transcriptional degradation of mRNAs
often involves miRNAs specific for the respective target
gene [12]. We have investigated miRNA-21 that has
been shown to suppress TGF-βRI and TGF-βRII [16].
Additionally, circulating miRNA-21 levels are increased
in men with a low aerobic capacity as measured by max-
imal oxygen uptake [52]. However, its levels were not
enhanced in RT or RTS groups, suggesting that other
mechanisms and/or other miRNAs are involved in the
down-regulation of TGF-βRI in PBMCs by strength
training [53].
One striking secondary outcome of this study is that
TGF-β, TGF-βRI and potentially TGF-βRII mRNA
expression at the beginning of the study were higher in
drop-outs compared with finishers, while miRNA-21
expression was lower. Drop-outs were less physically fit
than finishers. We confirmed that age, sex, body com-
position and the presence of several co-morbidities
might not contribute to this effect, but the proportion
of subjects with hyperlipidaemia was higher among
finishers.
Although this study provides interesting data on TGF-
β-related parameters in the context of inflammaging and
Table 4 Intervention effects on TGF-β signalling gene expression
Baseline (n = 67) 3 months (n = 67) 6 months (n = 67) P-value (time)
TGF-β/GAPDH [-]
CT (n = 21) 0.47 (0.23–2.66) 0.47 (0.27–4.10) 0.44 (0.25–1.93) 0.772
RT (n = 26) 0.54 (0.26–2.30) 0.52 (0.16–2.63) 0.52 (0.23–2.30) 0.568
RTS (n = 20) 0.55 (0.06–1.63) 0.45 (0.15–2.20) 0.56 (0.09–1.32) 0.692
TGF-βRI/GAPDH [-]
CT (n = 21) 1.99 (0.14–22.39) 1.62 (0.46–29.89) 1.97 (0.11–9.24) 0.717
RT (n = 26) 1.87 (0.69–9.54) 1.61 (0.34–9.21)* 1.77 (0.54–15.91) 0.006
RTS (n = 20) 1.95 (0.30–8.63) 1.63 (0.28–8.59) 2.38 (0.52–6.73) 0.801
TGF-βRII/GAPDH [-]
CT (n = 21) 1.54 (0.66–7.79) 1.39 (0.68–9.17) 1.48 (0.67–6.32) 0.827
RT (n = 26) 1.60 (0.66–14.86) 1.59 (0.57–13.50) 1.67 (0.63–8.79) 0.296
RTS (n = 20) 1.58 (0.51–5.13) 1.73 (0.44–3.98) 1.95 (0.69–4.73) 0.331
miRNA-21 [copies/pg RNA]
CT (n = 21) 3163 (343–4500) 2840 (276–5120) 2460 (1050–4700) 0.861
RT (n = 26) 2602 (57–4720) 2340 (758–5600) 2540 (330–5020) 0.368
RTS (n = 20) 2536 (845–4590) 2535 (353–4780) 2810 (1600–4630) 0.854
Data are expressed as medians (min–max); Differences were detected using the Friedman test and if significant, followed by Bonferroni-corrected
post-hoc analyses (* p < 0.05 vs. baseline; significant differences are marked in bold)
Abbreviations: CT cognitive training, RT resistance training, RTS resistance training plus supplement, TGF-β transforming growth factor-β, TGF-βR TGF-β receptor,
GAPDH glyceraldehyde 3-phosphate dehydrogenase, miR-21 microRNA-21
Table 5 Association between physical performance at baseline and the response of TGF-β-related parameters
Baseline performance
Handgrip strength Chair stand test Arm lifting test 6-MWT
Change (difference between
3 months and baseline)
Circulating TGF-β -0.039 -0.349* -0.352* -0.308*
TGF-β/GAPDH 0.103 0.220 -0.051 0.199
TGF-β RI/GAPDH 0.222 0.222 -0.148 0.148
TGF-β RII/GAPDH 0.142 0.254* -0.027 0.204
miRNA-21 0.201 0.143 -0.029 0.038
Data indicate Spearman-Rho correlation coefficients. * p < 0.05 (significant correlations are marked in bold)
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exercise training, we also have to highlight some of its
limitations. Because the study is a secondary analysis of
a previously conducted trial [22], it is obvious that the
data need to be confirmed in a future prospective study.
Similar to other studies, we were interested in additive
effects of the nutritional supplement to strength training
rather than investigating the effects of the supplement
alone. While this approach represents a best practice
model in exercise nutrition, this study design has a lim-
ited explanatory power in describing the observed differ-
ences between the RT and RTS groups. Finally, the
number of female participants outnumbered the male
participants by a significant degree. It also has to be
mentioned that the proportion of community-dwelling
men at an age of 85 years in Vienna is 34 % [54], but the
proportion of male individuals in Viennese retirement
homes is 19 % for this age group [55] making our study
population representative in terms of sex distribution of
institutionalised older individuals in Austria. Although it
was not possible to perform sub-group analyses because
of the low numbers of men, their exclusion led to the
same conclusion, indicating that the data are reliable at
least for older women.
Conclusions
Resistance training is beneficial, even in very old subjects,
and potentially influences TGF-β signalling through al-
tered receptor mRNA expression. Furthermore, adherence
to the intervention was significantly related to alterations
in the TGF-β pathway at baseline, but further information
is needed to clearly understand the role of TGF-β in
the context of inflammaging, resistance training and
nutritional supplementation.
Methods
Participants and study design
The study was conducted using a randomised observer-
blind design with three parallel groups, RT, RTS and CT.
Briefly, participants were untrained, over 65 years of age
with a Mini-Mental State Examination score of ≥23 and
free of any medical conditions that would impair their
participation in a resistance training study [56]. From a
total of 117 participants in the VAAS, only those with
available blood samples and a hs-CRP level below
10 mg/L at any time point were included in the current
study (n = 88). A detailed description of the study design
has been published previously [22].
Interventions
Interventions were conducted for 6 months, and measure-
ments were obtained at baseline, after 3 and 6 months.
Twice a week, RT and RTS groups performed supervised
progressive resistance training without using any equip-
ment other than elastic bands and their own body weight.
Each exercise session consisted of a general warm-up
of 10 min, followed by a resistance training session
(35–40 min) incorporating one to two exercises for
each of the six main muscle groups (legs, back, abdo-
men, chest, shoulder and arms), and was completed by
a cool-down routine. Following an adaptation phase of
4 weeks using low external resistance (yellow Thera-
Band®, 1 set of 15 repetitions per exercise with a higher
resistance only if the subject was obviously unchal-
lenged) exercise intensity was progressively increased
by changing the Thera-Band® from yellow to red and
further to black. Additionally, the exercise volume was
enhanced by increasing the number of sets from one to
two. Rate of progression was based on individual
improvements (band colour was changed if participant
would have been able to perform two more repetitions
in the second set. A detailed description has been
provided previously [22]. Additionally to the exercises,
participants from the RTS group were encouraged to
drink a supplement that was distributed every morning
as well as directly after the resistance training (in total
nine times per week). One portion consisted of 20.7 g
protein (55 En %; 19.7 g whey protein containing more
than 10 g essential amino acids including 3 g leucine),
9.4 g carbohydrates (25 En %), 3.0 g fat (18 En %), 1.2 g
fibre (2 En %), various vitamins such as 800 IU (20 μg)
vitamin D, minerals and trace elements (FortiFit; Nutricia
GmbH, Vienna, Austria). Total energy per drink was
150 kcal. Intake of the nutritional supplement was
controlled at breakfast as well as after each training
session. The CT group served as a control group and
performed activities based on cognitive tasks (memory
training) and coordinative tasks (such as manual dexterity)
twice weekly to provide a timely effort which was equal to
those of the RT and RTS groups, respectively [22, 57].
Determination of body composition, physical fitness
and health
Standing height was assessed using a commercial stadi-
ometer (Seca, Hamburg, Germany), Body mass was eval-
uated with a digital scale (BWB 700; Tanita, Amsterdam,
Netherlands) to the nearest 0.1 kg with subjects lightly
dressed and barefoot. BMI was calculated by dividing
the body mass in kilograms by height in meters squared.
To measure strength of the upper extremities, partici-
pants performed two trials of an isometric handgrip
strength test (kg) using a dynamometer (JAMAR com-
patible handgrip dynamometer adapted to handle vari-
ous hand sizes) in a sitting position with an angle of 90°
in the elbow [58]. Functional performance of the lower
extremities was measured by a chair stand test, and that
of the upper extremities by an arm-lifting test as de-
scribed previously [22, 59]. Aerobic capacity was assessed
by the 6MWT conducted on a 30-m shuttle track [60].
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Global cognitive function was determined by the Mini-
Mental State Examination [61]. Co-morbidities (hyperlip-
idaemia, hypertension, osteoporosis, cardiac diseases,
history of cancer and diabetes mellitus) were determined
at the medical entrance examination. Adiposity was
defined by a BMI of >30 kg/m2 according to the World
Health Organization criteria.
Blood sampling and analyses
After overnight fasting, venous blood samples were
obtained in a resting state between 06:30 and 08:00
using Z serum Clot Activator collection tubes (Vacuette®;
Greiner Bio-One GmbH, Kremsmünster, Austria) to ana-
lyse circulating TGF-β and hs-CRP, EDTA tubes (Vacuette®;
Greiner Bio-One GmbH) to determine leukocyte subpopu-
lations and BD Vacutainer® CPT Tubes (Becton, Dickenson
and Company, Schwechat, Austria) containing ~130 IU
Na-Heparin and 2 mL Ficoll™ to isolate PBMCs.
Hs-CRP was quantified on a Cobas 8000 (Roche Diag-
nostics, Vienna, Austria). Leukocyte subpopulations were
determined by flow cytometric analyses on a XE-2100
automated hematology system (Sysmex Austria GmbH,
Vienna, Austria). TGF-β was analysed using a commer-
cially available DuoSet development kit to perform an
enzyme-linked immunosorbent assay (DY240; R&D
Systems, Abingdon, UK) following the manufacturer’s in-
structions including plasma activation by acidification
(pH 2) by adding hydrochloric acid (final concentration:
0.1 mmol/L) and neutralisation with sodium hydroxide
(final concentration: 0.12 mmol/L) before measurement.
PBMCs were separated from red blood cells and neutro-
phils using BD Vacutainer® CPT Tubes (Becton Dickinson
Austria, Vienna, Austria). The obtained pellet was carefully
resuspended in 700 μL QIAzol Lysis Reagent (Qiagen,
Hilden, Germany) and stored at −80 °C until analysis.
Total RNA including small RNAs was isolated using a
miRNeasy Mini Kit (Qiagen, Hilden, Germany) following
the supplier’s protocol. To prepare a miRNA-enriched
fraction separated from the larger RNAs (>200 nt), we
used an RNeasy MinElute Cleanup Kit (Qiagen). Reverse
transcription of the miRNA-enriched fraction was
performed using a miScript II RT Kit (Qiagen), whereas
larger RNAs were reverse transcribed using a Quanti-
Tect Reverse Transcription Kit (Qiagen).
TGF-β, TGF-βRI and TGF-βRII mRNA levels were
determined using the respective primer pairs [Hs_TGFB1_1
(QT00000728), Hs_TGFBR1_1 (QT00083412) and
Hs_TGFBR2_1 (QT00014350); Qiagen] in conjunction
with a QuantiTect SYBR Green PCR kit (Qiagen). In
addition, glyceraldehyde-3-phosphate dehydrogenase
[Hs_GAPDH_2 (QT01192646)] served as the endogenous
control to normalise the data. Quantification was per-
formed on an Applied Biosystems® 7500 Real-Time
PCR System.
MiRNA-21 expression levels were detected using a
miScript Primer Assay specific for miRNA-21 [hs_miR-
21_2 (MS00009079); Qiagen]. Quantification was per-
formed on the Applied Biosystems® 7500 Real-Time
PCR System.
Statistical analyses
Data acquisition and processing were performed using
commercial software (IBM SPSS 20). The Shapiro–Wilk
test was used to test for a normal distribution. Because
most of the variables were not distributed normally, the
non-parametric Mann-Whitney U-test or the Kruskal-
Wallis test were used to compare two or more inde-
pendent groups, whereas the Friedman test was applied
to detect changes over time in different intervention
groups. To avoid bias by multiple testing, the results
were Bonferroni-corrected for post-hoc analyses. Corre-
lations between variables were identified by Spearman’s
rank correlation coefficient. Data are shown as the me-
dian (minimum–maximum). Statistical significance was
set at p < 0.05.
Abbreviations
BMI, body mass index; CT, cognitive training; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; hs-CRP, high sensitive C-reactive protein; IL-6, interleukin-6;
miRNA, microRNAv; PBMCs, peripheral mononuclear cells; RT, resistance training;
RTS, resistance training plus nutritional supplementation; TGF-β, transforming
growth factor-β; TGF-βR, TGF-β receptor; TNF-α, tumour necrosis factor-α;
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